Publications by authors named "Laetitia Zerkowski"
To determine the predictive factors of mortality after hospitalization for acute heart failure (AHF) in an internal medicine department. Retrospective observational analysis conducted on 164 patients hospitalized for AHF in 2016-2017. Demographic, clinical and biological characteristics were assessed during hospitalization.
View Article and Find Full Text PDFObjective: To explore the diagnostic contribution of the F-FDG-PET/CT in a population of patients with classical fever of unknown origin (FUO), to pinpoint its place in the diagnostic decision tree in a real-life setting, and to identify the factors associated with a diagnostic F-FDG-PET/CT.
Method: All adult patients (aged ≥ 18 years) with a diagnosis of classical FUO who underwent an F-FDG-PET/CT in the University Hospital of Montpellier (France) between April 2012 and December 2017 were included. True positive F-FDG-PET/CT, which evidenced a specific disease causing FUO, were considered to be contributive.
Background And Objectives: The optimization of immunosuppressive therapies has led to a marked improvement in the survival of ANCA-associated vasculitides (AAV). The main issue now appears to be the management of comorbidities and the improvement of quality of life. The objective of this review was to investigate the incidence and the impact of AAV-associated comorbidities, as well as the determinants of health-related quality of life (HRQoL).
View Article and Find Full Text PDFArticle Synopsis
- Medication errors (MEs) can be minimized through strategies like medication reconciliation, which are especially crucial for high-risk patients due to limited resources.
- A study conducted in a French university hospital identified risk factors for MEs during medication reconciliation using a score created from data collected from adult hospitalized patients over four years.
- The findings revealed specific risk factors such as female gender, taking more than seven medications, and admissions during off-hours, allowing healthcare providers to prioritize high-risk patients for better medication management.
Aims: Biomarkers are not recommended until now to guide the management of patients with heart failure (HF). Soluble suppression of tumorigenicity 2 (sST2) appears as a promising biomarker. The current study considered pre-discharged sST2 values as a guide for medical management in patients admitted for acute HF decompensation, in an attempt to reduce hospital readmission.
View Article and Find Full Text PDF